1. Signalling pathways in succinate dehydrogenase B-associated renal carcinoma.
- Author
-
Fleming S, Mayer NJ, Vlatkovic LJ, McLean J, McConachie M, and Baty D
- Subjects
- AMP-Activated Protein Kinases metabolism, Adult, Aged, Carcinoma, Renal Cell pathology, Cyclin D1 metabolism, Female, Glycogen Synthase Kinase 3 metabolism, Humans, Immunohistochemistry, Kidney Neoplasms pathology, Middle Aged, Phosphorylation, Signal Transduction, TOR Serine-Threonine Kinases metabolism, Carcinoma, Renal Cell genetics, Carcinoma, Renal Cell metabolism, Germ-Line Mutation, Kidney Neoplasms genetics, Kidney Neoplasms metabolism, Succinate Dehydrogenase genetics
- Abstract
Aims: Renal tumours have recently been described in association with mutations in the gene encoding the B subunit of succinate dehydrogenase, a mitochondrial Krebs cycle and electron transport chain enzyme (SDHB-associated renal cell carcinomas). The aim of this study was to investigate the roles of different signalling pathways in the pathogenesis of these tumours., Methods and Results: We used immunohistochemistry and antibodies against phospho-specific epitopes to examine the activity of three potential signalling pathways in tumour cells of three genetically confirmed cases of SDHB-associated renal cell carcinomas. We found no evidence supporting a role for either the mTOR [p-mTOR (Ser2448), p-S6 riboprotein (Ser235/236)] or hypoxia-inducible (carbonic anhydrase 9 and EGFR) pathways. However, there was immunohistochemical reactivity for phosphorylated AMP-dependent kinase (p-AMPK Thr172) and glycogen synthase kinase 3 (GSK3) phosphorylation (p-GSK3 Ser12), and nuclear expression of cyclin D1., Conclusions: We suggest that these tumours may arise through a mechanism involving ATP depletion, activation of AMPK, and induction of cyclin D1, and that this may be a unique pathway of tumour development that has the potential for therapeutic intervention in these rare tumours., (© 2013 John Wiley & Sons Ltd.)
- Published
- 2014
- Full Text
- View/download PDF